Multi‐Omics Reveals Mechanisms of Metabolic Rejuvenation in Aged Mice and Pre‐Frail Older Men by Losartan
Authors:
Open Access
- 22 April 2026
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 25 (5) , e70498
Abstract
Aging is associated with significant alterations in systemic metabolism across species. We employed targeted metabolomics to investigate the effects of losartan, an angiotensin II receptor blocker, on the serum metabolome of aged mice and pre‐frail older men. Losartan treatment resulted in a shift in serum metabolome aging signature to a more youthful state. This rejuvenation effect appears to be contingent on the presence of functional angiotensin II receptors, with receptor knockout mice showing no rejuvenation effect with treatment. Additionally, we observed a similar rejuvenation effect of losartan in the cardiac proteome of aged mice, with the most pronounced changes occurring in proteins involved in oxidative phosphorylation. While our study did not encompass a full lifespan analysis, in alignment with previous reports of lifespan extension in other models, we noted a statistically significant improvement in survival among geriatric mice treated with losartan. In parallel, we analyzed serum metabolomics data from pre‐frail older men from a phase 2 randomized placebo‐controlled trial of losartan, which indicated a dose‐dependent metabolic rejuvenation effect. Correlation network analysis revealed divergent aging effects between species, with mice exhibiting broad decreases in metabolite concentrations and humans showing increases, particularly across lipid species. Principal component analysis further highlighted a global shift in metabolite levels, potentially linked to changes in lipoprotein metabolism, plasma volume, and amino acid metabolism with age. In summary, our results suggest that losartan can partially reverse age‐related metabolomic changes in both male mice and humans, with distinct species‐specific responses.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5T32AR048522‐20)
This publication has 30 references indexed in Scilit:
- Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction MonitoringAnalytical Chemistry, 2021
- Fasting blood glucose as a predictor of mortality: Lost in translationCell Metabolism, 2021
- Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometryJournal of Chromatography A, 2020
- Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac DeathJournal of Proteome Research, 2016
- Losartan improves measures of activity, inflammation, and oxidative stress in older miceExperimental Gerontology, 2014
- Age-Associated Abnormalities of Water HomeostasisEndocrinology and Metabolism Clinics of North America, 2013
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Vascular Response to Angiotensin II Is Exaggerated through an Upregulation of AT1 Receptor in AT2 Knockout MiceBiochemical and Biophysical Research Communications, 1999
- Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptorNature, 1995
- Regulation of blood pressure by the type 1A angiotensin II receptor gene.Proceedings of the National Academy of Sciences, 1995